Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (55) Nicorette (nicotine polacrilex), SmithKline Beecham,
...Newly Approved Drug Therapies (55) Nicorette (nicotine polacrilex), SmithKline Beecham, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Nicorette (nicotine polacrilex) Company: SmithKline Beecham Approval Status: Approved February 1996 Treatment Area: smoking cessation General Information ...
View Page

2.  Newly Approved Drug Therapies (322) Generic Transdermal Nicotine Patch, Sano,
...Newly Approved Drug Therapies (322) Generic Transdermal Nicotine Patch, Sano, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Generic Transdermal Nicotine Patch Company: Sano Approval Status: Approved October 1997 Treatment Area: smoking cessation General Information Sano ...
View Page

3.  Study Posting (3940) Trial #79632, Substance Abuse, Belmont, MA
...Trial #79632, Substance Abuse, Belmont, MA Healthy women who smoke heavily are needed for a nicotine study on hormones and mood" /> Trial Information Belmont: McLean Hospital Healthy women who smoke heavily are needed for a nicotine study on hormones and mood If you are: • A woman • Ages 18-40 • In good ...
View Page

4.  Study Posting (3940) Trial #77462, Women's Health, Belmont, MA
...77462, Women's Health, Belmont, MA Healthy women who smoke heavily are needed for a nicotine study on hormones and mood" /> Trial Information Belmont: McLean Hospital Healthy women who smoke heavily are needed for a nicotine study on hormones and mood If you are: • A woman • Ages 18-40 • In good ...
View Page

5.  CenterWatch: New Medical Therapies in Disease Category (237), Smoking Cessation
...positive nine-month data from a phase IIb trial of NicVAX for the treatment of nicotine addiction and relapse. This double-blind, placebo-controlled, dose-ranging trial enrolled 301 heavy smokers ...
...results of a phase I trial of their vaccine TA-NIC , for the treatment of nicotine addiction. Study data yielded evidence of efficacy, with a greater incidence of quitting for both ...
View Page

6.  Study Posting (4720) Trial #162626, *Healthy Patient Studies, Durham, NC
...Treatment Response and Genotype The purpose of this study is to assess the value of nicotine patch treatment before quitting and comparing Zyban and Chantix treatments, as steps towards helping you quit smoking successfully. We also want to see if smokers who receive nicotine patches should be switched to Zyban or Chantix based on their initial response to the ...
View Page

7.  Newly Approved Drug Therapies (75) Nicotrol nasal spray, Pharmacia & Upjohn,
...cessation General Information Nicotrol NS is a pump bottle that holds 100 milligrams of pure nicotine that smokers can inhale to ward off cigarette cravings. It is to be sold by prescription only to adult smokers trying to quit. The nicotine nasal spray hits the bloodstream faster than the gum or patch, offering the potential of ...
View Page

8.  Study Posting (799) Trial #158277, Memory Loss, Boston, MA
...and Without Schizophrenia" /> Trial Information A Double-Blind, Placebo-Controlled Trial of Effects of Transdermal Nicotine on Cognitive Function in Non-smokers With and Without Schizophrenia Are you or someone you ...
...centerwatch.com psinclair1@partners.org A Double-Blind, Placebo-Controlled Trial of Effects of Transdermal Nicotine<br/>on Cognitive Function in Non-smokers With and Without Schizophrenia Memory Loss ...
View Page

9.  Newly Approved Drug Therapies (151) NicoDerm CQ, SmithKline Beecham, Hoechst Marion Roussel, Alza,
...has been approved as an OTC stop smoking aid. NicoDerm CQ is the first OTC nicotine patch to be available in all prescription strengths: 21 mg, 14 mg, and 7 mg ...
...day. NicoDerm CQ provides a step down program that allows smokers to gradually reduce their nicotine intake, rather than stop abruptly. Most smokers should start with Step 1 (21 mg) for ...
View Page

10.  Study Posting (799) Trial #158278, Schizophrenia and Schizoaffective Disorders, Boston, MA
...and Without Schizophrenia" /> Trial Information A Double-Blind, Placebo-Controlled Trial of Effects of Transdermal Nicotine on Cognitive Function in Non-smokers With and Without Schizophrenia Are you or someone you ...
...centerwatch.com psinclair1@partners.org A Double-Blind, Placebo-Controlled Trial of Effects of Transdermal Nicotine<br/>on Cognitive Function in Non-smokers With and Without Schizophrenia Schizophrenia and ...
View Page

11.  Study Posting (799) Trial #158266, Schizophrenia and Schizoaffective Disorders, Boston, MA
...and Without Schizophrenia" /> Trial Information A Double-Blind, Placebo-Controlled Trial of Effects of Transdermal Nicotine on Cognitive Function in Non-smokers With and Without Schizophrenia Are you or someone you ...
...centerwatch.com psinclair1@partners.org A Double-Blind, Placebo-Controlled Trial of Effects of Transdermal Nicotine<br/>on Cognitive Function in Non-smokers With and Without Schizophrenia Schizophrenia and ...
View Page

12.  Study Posting (573) Trial #159819, Smoking Cessation, Raleigh, NC
...a smoking cessation research study of an investigational vaccine intended to block the effects of nicotine and help you quit smoking. Study participants must: • Be aged 18 to 65 • Have smoked ...
View Page

13.  Study Posting (573) Trial #159820, *Healthy Patient Studies, Raleigh, NC
...a smoking cessation research study of an investigational vaccine intended to block the effects of nicotine and help you quit smoking. Study participants must: • Be aged 18 to 65 • Have smoked ...
View Page

14.  Newly Approved Drug Therapies (897) Chantix (varenicline), Pfizer,
...is a partial nicotinic acetylcholine receptor agonist, designed to partially activate this system while displacing nicotine at its sites of action in the brain. Chantix is specifically indicated for use as ...
...or non-nicotinic receptors and transporters (>2000-fold). The drug competitively inhibits the ability of nicotine to bind to and activate the alpha-4 beta-2 receptor. The drug exerts mild ...
View Page

15.  Study Posting (5386) Trial #156102, Men's Health, Evansville, IN
...an investigational medication you must be: • A healthy man age 18 to 50 • Tobacco and nicotine-free • Willing to stay at Covance for 3 nights / 4 days on 2 occasions and ...
View Page

16.  Newly Approved Drug Therapies (261) Zyban Sustained-Release Tablets, GlaxoSmithKline,
...Tablets have been approved for use as a smoking cessation treatment. It is the first nicotine-free prescription medicine available. It is also the first smoking cessation treatment available in tablet ...
...Zyban was compared to placebo; in the other study, Zyban was evaluated versus placebo, a nicotine patch (Habitrol (R)(1)), and in combination with the patch. In both studies, all patients ...
View Page

17.  Study Posting (5388) Trial #156104, *Healthy Patient Studies, Evansville, IN
...an investigational medication you must be: • A healthy man age 18 to 50 • Tobacco and nicotine-free • Willing to stay at Covance for 3 nights / 4 days on 2 occasions and ...
View Page

18.  CenterWatch: Psychiatry/Psychology Approved Drug Therapies
...Disorder, Approved February 2007 Drugs Approved in 2006 Chantix (varenicline) ; Pfizer; For the treatment of nicotine addiction, Approved May 2006 Invega (paliperidone) ; Janssen Pharmaceutica; For the treatment of schizophrenia, Approved December ...
...in 1997 Effexor XR (venlafaxin HCI) ; Wyeth; Treatment of depression, Approved October 1997 Generic Transdermal Nicotine Patch ; Sano; Generic equivalent of Habitrol, Approved October 1997 LUVOX (fluvoxamine maleate) ; Solvay Pharmaceuticals, Pharmacia ...
View Page

19.  Study Posting (5316) Trial #151342, Alzheimer's Disease, Gainesville, FL
...Food and lodging will be provided to you during your overnight stays. Drug, alcohol, and nicotine testing will be done. Patient Inclusion Criteria: Males and females between the ages of 65-85 in good general health. Should not have smoked or used nicotine products (i.e. patches, mints, gum) for at least 6 months. Please call our recruiting ...
View Page

20.  Study Posting (5316) Trial #151341, Alzheimer's Disease, Gainesville, FL
...Food and lodging will be provided to you during your overnight stays. Drug, alcohol, and nicotine testing will be done. Patient Inclusion Criteria: Males and females between the ages of 65-85 in good general health. Should not have smoked or used nicotine products (i.e. patches, mints, gum) for at least 6 months. Please call our recruiting ...
View Page